Short-term Outcomes of Intraoperative Cell Saver Transfusion during Open Partial Nephrectomy

Urology

Volumn 86, Issue 6, 2015, Pages 1153-1158

  Lyon, Timothy D ^a   Ferroni, Matthew C ^a   Turner, Robert M ^a   Jones, Cameron ^a   Jacobs, Bruce L ^a   Davies, Benjamin J ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE EFFECTS; AGED; BLOOD AUTOTRANSFUSION; BLOOD SALVAGE; CARCINOMA, RENAL CELL; ETIOLOGY; FEMALE; FOLLOW UP; HUMAN; ISCHEMIA; KIDNEY NEOPLASMS; LENGTH OF STAY; MALE; MIDDLE AGED; NEPHRECTOMY; OPERATION DURATION; OPERATIVE BLOOD LOSS; PROCEDURES; RETROSPECTIVE STUDY; TIME FACTOR; TREATMENT OUTCOME; TUMOR RECURRENCE;

AGED; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION, AUTOLOGOUS; CARCINOMA, RENAL CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY NEOPLASMS; LENGTH OF STAY; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEPHRECTOMY; OPERATIVE BLOOD SALVAGE; OPERATIVE TIME; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; WARM ISCHEMIA;

EID: 84955741111     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2015.09.008     Document Type: Article

References (28)

1. R.L. Siegel, K.D. Miller, and A. Jemal Cancer statistics, 2015 CA Cancer J Clin 65 2015 5 29
2. I.S. Gill, L.R. Kavoussi, B.R. Lane, and et al. Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors J Urol 178 2007 41 46
3. B.J. Linder, R.H. Thompson, B.C. Leibovich, and et al. The impact of perioperative blood transfusion on survival after nephrectomy for non-metastatic renal cell carcinoma (RCC) BJU Int 114 2014 368 374
4. Y.S. Tanagho, J.H. Kaouk, M.E. Allaf, and et al. Perioperative complications of robot-assisted partial nephrectomy: analysis of 886 patients at 5 United States centers Urology 81 2013 573 579
5. M. Hadjipavlou, F. Khan, S. Fowler, and et al. Partial vs radical nephrectomy for T1 renal tumours: an analysis from the British Association of Urological Surgeons Nephrectomy Audit e-pub ahead of print BJU Int 2015 10.1111/bju.13114 accessed October 21, 2015
6. A. Soubra, J.R. Zabell, O. Adejoro, and et al. Effect of perioperative blood transfusion on mortality for major urologic malignancies Clin Genitourin Cancer 13 2015 e173 e181
7. N. Blumberg, and J.M. Heal Effects of transfusion on immune function. Cancer recurrence and infection Arch Pathol Lab Med 118 1994 371 379
8. T. Upile, W. Jerjes, J. Mahil, and et al. Blood product transfusion and cancer prognosis Clin Adv Hematol Oncol 7 2009 656 661
9. E.C. Vamvakas, and M.A. Blajchman Transfusion-related immunomodulation (TRIM): an update Blood Rev 21 2007 327 348
10. P.B. Yaw, M. Sentany, W.J. Link, and et al. Tumor cells carried through autotransfusion. Contraindication to intraoperative blood recovery? JAMA 231 1975 490 491
11. R.F. Dale, R.M. Kipling, M.F. Smith, and et al. Separation of malignant cells during autotransfusion Br J Surg 75 1988 581
12. D.M. Karczewski, M.J. Lema, and D. Glaves The efficiency of an autotransfusion system for tumor cell removal from blood salvaged during cancer surgery Anesth Analg 78 1994 1131 1135
13. D. MacIvor, J. Nelson, and D. Triulzi Impact of intraoperative red blood cell salvage on transfusion requirements and outcomes in radical prostatectomy Transfusion 49 2009 1431 1434
14. J.H. Waters, M. Yazer, Chen Y.F., and et al. Blood salvage and cancer surgery: a meta-analysis of available studies Transfusion 52 2012 2167 2173
15. C.L. Gray, C.L. Amling, G.R. Polston, and et al. Intraoperative cell salvage in radical retropubic prostatectomy Urology 58 2001 740 745
16. A.M. Nieder, A.J. Carmack, P.D. Sved, and et al. Intraoperative cell salvage during radical prostatectomy is not associated with greater biochemical recurrence rate Urology 65 2005 730 734
17. A.M. Nieder, M. Manoharan, Yang Y., and et al. Intraoperative cell salvage during radical cystectomy does not affect long-term survival Urology 69 2007 881 884
18. A. Mukkamala, C.L. Allam, J.S. Ellison, and et al. Tumor enucleation vs sharp excision in minimally invasive partial nephrectomy: technical benefit without impact on functional or oncologic outcomes Urology 83 2014 1294 1299
19. R. Stephens, and S.D. Graham Jr Enucleation of tumor versus partial nephrectomy as conservative treatment of renal cell carcinoma Cancer 65 1990 2663 2667
20. P. Puppo, C. Introini, P. Calvi, and et al. Long term results of excision of small renal cancer surrounded by a minimal layer of grossly normal parenchyma: review of 94 cases Eur Urol 46 2004 477 481
21. D. Glaves, R.P. Huben, and L. Weiss Haematogenous dissemination of cells from human renal adenocarcinomas Br J Cancer 57 1988 32 35
22. L. Weiss Metastatic inefficiency Adv Cancer Res 54 1990 159 211
23. A. Goldkorn, B. Ely, D.I. Quinn, and et al. Circulating tumor cell counts are prognostic of overall survival in SWOG S0421: a phase III trial of docetaxel with or without atrasentan for metastatic castration-resistant prostate cancer J Clin Oncol 32 2014 1136 1142
24. H.I. Scher, Jia X., J.S. de Bono, and et al. Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data Lancet Oncol 10 2009 233 239
25. N. Kumar, R. Lam, A.S. Zaw, and et al. Flow cytometric evaluation of the safety of intraoperative salvaged blood filtered with leucocyte depletion filter in spine tumour surgery Ann Surg Oncol 21 2014 4330 4335
26. M.J. Edelman, P. Potter, K.G. Mahaffey, and et al. The potential for reintroduction of tumor cells during intraoperative blood salvage: reduction of risk with use of the RC-400 leukocyte depletion filter Urology 47 1996 179 181
27. G.V. Miller, C.W. Ramsden, and J.N. Primrose Autologous transfusion: an alternative to transfusion with banked blood during surgery for cancer Br J Surg 78 1991 713 715
28. D.M. Moskowitz, S.I. Perelman, K.M. Cousineau, and et al. Multidisciplinary management of a Jehovah's Witness patient for the removal of a renal cell carcinoma extending into the right atrium Can J Anaesth 49 2002 402 408